Aldosterone blockade attenuates development of an electrophysiological substrate associated with ventricular tachyarrhythmias in heart failure
To access this article, please choose from the options below
Supported by research grants from Pfizer, Inc., and the American Heart Association Ohio Valley to Dr. Stambler.
PII: S1547-5271(09)00130-1
doi:10.1016/j.hrthm.2009.02.005
© 2009 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
